Table 6 Variance components analysis and intraclass correlation coefficients of country and panel agreements with three valuation methods.
From: Cross-national agreement on disability weights: the European Disability Weights Project
Visual analogue scale (15 disease stages) | Visual analogue scale (9 disease stages) | Time trade-off (9 disease stages) | Person trade-off (9 disease stages) | |
|---|---|---|---|---|
Random-effects | Proportion of total variance | |||
Subject nested within panel* | 4.3% | 5.4% | 9.8% | 16.4% |
Panel nested within country | 0,0 | 0,0 | 0.7% | 2.7% |
Country | 0.7% | 0.1% | 1.2% | 3.9% |
Disease | 66.5% | 65.4% | 61.2% | 36.7% |
Disease effect crossed with: | ||||
- panel nested within country | 0.8% | 1.3% | 0.4% | 0.3% |
- country | 1.9% | 1.8% | 1.8% | 6.9% |
Residual | 25.8% | 26.0% | 24.9% | 33.2% |
Intraclass correlation coefficient of country agreement** | ||||
0.72 (0.65–0.77) | 0.72 (0.70–0.74) | 0.72 (0.69–0.75) | 0.56 (0.52–0.62) | |
Intraclass correlation coefficient of panel agreement** | ||||
0.73 (0.67–0.79) | 0.73 (0.71–0.75) | 0.74 (0.72–0.77) | 0.64 (0.58–0.68) | |